Obesity Pharmacotherapy in Patients With Type 2 Diabetes

Por Kahan, Scott, Fujioka, Ken
Publicado no Diabetes Spectr (2017)

Update on bariatric surgical procedures and an introduction to the implantable weight loss device: the Maestro Rechargeable System

Por Hwang, Stephanie S, Takata, Mark C, Fujioka, Ken, Fuller, William
Publicado no Med Devices (Auckl) (2016)

Method‐of‐use study of naltrexone sustained release (SR)/bupropion SR on body weight in individuals with obesity

Por Halseth, Amy, Shan, Kevin, Walsh, Brandon, Gilder, Kye, Fujioka, Ken
Publicado no Obesity (Silver Spring) (2016)

Usability of the Novel Liraglutide 3.0 mg Pen Injector Among Overweight or Obese Adult Patients With or Without Prior Injection Experience

Por Fujioka, Ken, Sparre, Thomas, Sun, Lily Yong-Hui, Krogsgaard, Susanne, Kushner, Robert F.
Publicado no J Diabetes Sci Technol (2015)

Genotype 1 hepatitis E virus infection with acute acalculous cholecystitis as an extrahepatic symptom: a case report

Por Fujioka, Ken, Nishimura, Toshiki, Seki, Masayuki, Kinoshita, Masanori, Mishima, Nobuyuki, Irimajiri, Shigeo, Yamato, Masaya
Publicado no Trop Med Health (2016)

Patients With Short Bowel on Narcotics During 2 Randomized Trials Have Abdominal Complaints Independent of Teduglutide

Por Fujioka, Ken, Jeejeebhoy, Khursheed, Pape, Ulrich-Frank, Li, Benjamin, Youssef, Nader N., Schneider, Stéphane M.
Publicado no JPEN J Parenter Enteral Nutr (2016)

Obesity Impairs γδ T Cell Homeostasis and Antiviral Function in Humans

Por Costanzo, Anne E., Taylor, Kristen R., Dutt, Shelley, Han, Peggy P., Fujioka, Ken, Jameson, Julie M.
Publicado no PLoS One (2015)

Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabete...

Por Hollander, Priscilla, Gupta, Alok K., Plodkowski, Raymond, Greenway, Frank, Bays, Harold, Burns, Colleen, Klassen, Preston, Fujioka, Ken
Publicado em 2013

Coadministration of lorcaserin and phentermine for weight management: A 12‐week, randomized, pilot safety study

Por Smith, Steven R., Garvey, W. Timothy, Greenway, Frank L., Zhou, Sharon, Fain, Randi, Pilson, Robert, Fujioka, Ken, Aronne, Louis J.
Publicado no Obesity (Silver Spring) (2017)

Long-Term Teduglutide for the Treatment of Patients With Intestinal Failure Associated With Short Bowel Syndrome

Por Schwartz, Lauren K, O'Keefe, Stephen J D, Fujioka, Ken, Gabe, Simon M, Lamprecht, Georg, Pape, Ulrich-Frank, Li, Benjamin, Youssef, Nader N, Jeppesen, Palle B
Publicado no Clin Transl Gastroenterol (2016)

Early Weight Loss with Liraglutide 3.0 mg Predicts 1‐Year Weight Loss and is Associated with Improvements in Clinical Markers

Por Fujioka, Ken, O'Neil, Patrick M., Davies, Melanie, Greenway, Frank, C.W. Lau, David, Claudius, Birgitte, Skjøth, Trine Vang, Bjørn Jensen, Christine, P.H. Wilding, John
Publicado no Obesity (Silver Spring) (2016)

Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome

Por Iyer, Kishore R., Kunecki, Marek, Boullata, Joseph I., Fujioka, Ken, Joly, Francisca, Gabe, Simon, Pape, Ulrich-Frank, Schneider, Stéphane M., Virgili Casas, María Nuria, Ziegler, Thomas R., Li, Benjamin, Youssef, Nader N., Jeppesen, Palle B.
Publicado no JPEN J Parenter Enteral Nutr (2016)